Xspray-logo-white
  • Home
  • About us
    • Business model
    • Our history – a timeline
    • Board of Directors & Board committees
    • Management
  • Technology
  • Pipeline
  • Media
  • Contact
  • Investors
  • en en
    • sv sv
  • Investors
    • Share information
      • Ownership structure
    • Financial calendar
    • Financial reports
      • ESEF report
    • Prospectus
    • Press releases
    • Corporate governance
      • Corporate Structure
      • General meetings
      • Corporate Governance Reports
      • Nomination committee
      • Board of Directors & Board committees
      • Management
      • Accounting principles
      • Internal control & Risk management
      • Auditor
      • Articles of association
      • Remuneration

Press releases

All press releases Regulatory

Regulatory press release 2018-10-25

Notice of extraordinary general meeting in Xspray Pharma AB (publ)

Regulatory press release 2018-10-10

Xspray Pharma’s HyNap-Dasa Shows Formal Bioequivalence

Regulatory press release 2018-09-24

Ribbskottet AB increases its stake in Xspray Pharma

Regulatory press release 2018-09-09

Xspray Pharma announces positive clinical data for its lead product candidate HyNap-Dasa

Press release 2018-08-02

Xspray Pharma and NerPharMa deliver clinical trial material to HyNap-Dasa study

Press release 2018-06-21

Xspray Pharma gets go-ahead from the Swedish MPA for clinical study

Press release 2018-05-16

Xspray Pharma Chariman divests 4,000 shares to cover Danish capital gains tax on unrealised gains on Xspray Pharma shares

Press release 2018-04-11

Notice of annual general meeting in Xspray Pharma AB (publ)

Press release 2018-02-20

Bulletin from the extraordinary general meeting of Xspray Pharma AB (publ)

Press release 2018-01-31

Notice of extraordinary general meeting in Xspray Pharma AB (publ)

Show more

IR contact

Jacob Nyberg, IRO

+46 (0)70 767 08 83

info@xspray.com

Subscribe

  • This field is for validation purposes and should be left unchanged.
  • Submit to our press releases and get an email every time we publish a press release or report on our website.
  • When clicked on Send I agree that my personal information will be saved. Read more
Xspray-logo-white

Xspray Pharma AB Scheeles väg 2 171 65 Solna

+46 (0)8 730 37 00 info@xspraypharma.com